Fibrinogen Early In Severe Trauma studY

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

January 20, 2018

Study Completion Date

February 20, 2018

Conditions
TraumaHaemorrhageCoagulopathy
Interventions
DRUG

Fibrinogen Concentrate

"Fibrinogen Replacement using Fibrinogen Concentrate as per ROTEM guided treatment algorithm \[FIBTEM ≤ A5 10mm\]~FIBTEM A5 0mm (Flat Line) = 6g FC FIBTEM A5 1 - 4mm = 5g FC FIBTEM A5 5 - 6mm = 4g FC FIBTEM A5 7 - 8mm = 3g FC FIBTEM A5 9 - 10mm = 2g FC"

OTHER

Cryoprecipitate

"Fibrinogen replacement using Cryoprecipitate as per ROTEM guided treatment algorithm \[FIBTEM A5 ≤ 10mm\]~FIBTEM A5 0mm (Flat Line) = 20 Units Cryo FIBTEM A5 1- 4mm = 16 Units Cryo FIBTEM A5 5 - 6mm = 14 Units Cryo FIBTEM A5 7 - 8mm = 10 Units Cryo FIBTEM A5 9 - 10mm = 8 Units Cryo"

Trial Locations (4)

4029

Royal Brisbane and Women's Hospital, Brisbane

4102

Princess Alexandra Hospital, Brisbane

4215

Gold Coast University Hospital, Gold Coast

4814

Townsville Hospital, Townsville

Sponsors
All Listed Sponsors
collaborator

Emergency Medicine Foundation

OTHER

collaborator

National Blood Authority

OTHER

collaborator

Australian Red Cross

OTHER

lead

Gold Coast Hospital and Health Service

OTHER_GOV

NCT02745041 - Fibrinogen Early In Severe Trauma studY | Biotech Hunter | Biotech Hunter